Non Inferiority Study of Preoperative Chemotherapy Without Pelvic Irradiation for Rectal Cancer (NORAD01)
Non Inferiority Multicenter Phase III Randomized Trial Comparing Preoperative Chemotherapy Only to Chemotherapy Followed by Chemoradiotherapy for Locally Advanced Resectable Rectal Cancer (Intergroup FRENCH-GRECCAR- PRODIGE)
Sponsor: Assistance Publique - Hôpitaux de Paris
This PHASE3 trial investigates Advanced Cancer and Rectal Cancer and is currently actively recruiting participants. Assistance Publique - Hôpitaux de Paris leads this study, which shows 14 recorded versions since 2019 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
14 versions recorded-
Feb 2026 — Present [monthly]
Recruiting PHASE3
-
Oct 2025 — Feb 2026 [monthly]
Recruiting PHASE3
-
Jul 2025 — Oct 2025 [monthly]
Recruiting PHASE3
-
Feb 2025 — Jul 2025 [monthly]
Recruiting PHASE3
-
Sep 2024 — Feb 2025 [monthly]
Recruiting PHASE3
▶ Show 9 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE3
-
Apr 2024 — Jul 2024 [monthly]
Recruiting PHASE3
-
Sep 2023 — Apr 2024 [monthly]
Recruiting PHASE3
-
Jul 2022 — Sep 2023 [monthly]
Recruiting PHASE3
-
Jan 2021 — Jul 2022 [monthly]
Recruiting PHASE3
-
Jun 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Feb 2020 — Jun 2020 [monthly]
Recruiting PHASE3
-
Aug 2019 — Feb 2020 [monthly]
Recruiting PHASE3
Status: Not Yet Recruiting → Recruiting
-
Apr 2019 — Aug 2019 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
For direct contact, visit the study record on ClinicalTrials.gov .